Details of the Drug Reposition

General Information of This Drug (ID: DM4JZIM)

Drug Name
Gilotrifafatinib   DM4JZIM

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lung squamous cell carcinoma DISXPIBD 2C25.2 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rhabdomyosarcoma DISNR7MS 2B55 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)